ArticleBMC musculoskeletal disorders2026
Impact of surface structuring on antibiotic elution from bone cement in two-stage revision for periprosthetic joint infection.
Article in BMC musculoskeletal disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposePeriprosthetic joint infection (PJI) is a serious complication after total joint arthroplasty and the leading cause of revision surgery. Two-stage revision with prosthesis removal, radical debridement, and interim antibiotic-loaded bone cement (ALBC) spacers is the current gold standard. ALBC spacers provide high local antibiotic concentrations and maintain joint space, with articulating designs improving interim mobility. Antibiotic release depends on cement composition, antibiotic content, and surface area, but the impact of surface structure remains unclear. This study investigated how surface morphology and area affect gentamicin and vancomycin release from ALBC in vitro.
methodsCopal G + V cement (2 g vancomycin, 0.5 g gentamicin per 43 g) was cast into standardized rectangular blocks according to DIN ISO 5833. A reference group without surface structuring and three groups with progressively increasing surface area and depth were analyzed. After polymerization, specimens were incubated in phosphate-buffered saline at 37 °C. Antibiotic release was measured at defined intervals over six weeks using chemiluminescence immunoassay (CLIA).
resultsSurface structuring resulted in a clear increase in cumulative antibiotic release, particularly for vancomycin, with a consistent relationship between surface enlargement and total elution. The greatest surface structuring led to the highest release levels. Gentamicin showed a similar but less pronounced response, with a notable increase only at the highest degree of surface enlargement. The initial burst release contributed substantially to overall elution, while later-phase release differences between groups were less marked.
conclusionSurface modification of PMMA cement influenced antibiotic elution in this in vitro experimental model, with increased surface depth resulting in enhanced vancomycin release. Gentamicin elution was less affected by surface geometry and showed significant improvement only with the greatest surface enlargement. These findings indicate that structured cement surfaces may influence local antibiotic release characteristics under controlled laboratory conditions. However, the clinical relevance of these surface modifications remains to be determined, as this study was limited to cement blocks incubated in phosphate-buffered saline and did not include a spacer, infection, or in vivo model. Further experimental and in vivo investigations are required to assess whether surface structuring can improve antibiotic delivery in clinically relevant settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.